JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB237642

Bevacizumab ELISA Kit

Be the first to review this product! 리뷰 제출

|

(3 제품이 사용된 논문 )

Bevacizumab ELISA Kit is a sandwich ELISA designed to quantify Bevacizumab with a sensitivity of 30 ng/mL.

- Colorimetric sandwich ELISA - 450 nm readout - works on any plate reader
- Can be used for pharmacokinetic (PK)s studies
- Wide dynamic range - quantifies 30 - 1000 ng/mL
- For Research Use Only - Not intended for diagnostic use
1 이미지
Sandwich ELISA - Bevacizumab ELISA Kit (AB237642)
  • sELISA

Supplier Data

Sandwich ELISA - Bevacizumab ELISA Kit (AB237642)

Example of Bevacizumab standard curve.

Typical Standard Curve : This standard curve is for demonstration only. A standard curve must be run with each assay.

주요 정보

검출 방식

Colorimetric

샘플 타입

Plasma, Serum

Reacts with

Human

결과 유형

Quantitative

Sensitivity

= 30 ng/mL

검출 범위

30 - 1000 ng/mL

분석 플랫폼

Microplate

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

제품 세부 정보

Bevacizumab ELISA Kit ab237642 is a sandwich ELISA to measure Bevacizumab in serum, plasma with a sensitivity of 30 ng/mL.

How the assay works:

Note: Bevacizumab ELISA kit ab237642 is intended for Research Use Only, not for use in diagnostic procedures.

This kit is a sandwich based ELISA kit. The color developed is proportional to the amount of Bevacizumab in the sample or standard. Results of samples can be determined directly using the standard curve.

Assay Specificity

Our ELISA kits are rigorously validated to ensure the highest level of consistency and reproducibility. Please check the protocol booklet for more details

Bevacizumab ELISA Kit ab237642 protocol summary

1. Add 100 µL of Assay buffer to each well and add 25 µL standard or sample to appropriate wells
2. Cover and incubate for 30 minutes at room temperature
3. Discard incubation solution and wash plate 3 times with 300 µL diluted Wash Buffer,
4. Add 100 µL HRP-conjugate to each well. Cover and incubate for 30 minutes at room temperature
5. Discard the solution and wash plate 3 times with 300 µL diluted Wash Buffer
6. Add 100 µL TMB Substrate and incubate the plate in the dark at room temperature for 10 minutes.
7. Add 100 µL Stop Solution and read OD at 450 nm within 20 minutes.

This product is manufactured by BioVision, an Abcam company and was previously called E4373 BioSim™ Bevacizumab (Human) ELISA Kit. E4373-100 is the same size as the 96 test size of ab237642.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Precision

[ { "reproducibilityType": "Intra", "sample": "Overall", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "< 30" }, { "reproducibilityType": "Inter", "sample": "Overall", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "< 30" } ]

Recovery

[ { "sample": "Serum", "range": "70 - 130 %", "average": null } ]

제품 구성

{ "values": { "96Test": { "sellingSize": "96 Test", "publicAssetCode":"ab237642-96Test", "assetComponentDetails": [ { "size":"2 x 50 mL", "name":"Assay Buffer", "number":"AB237642-CMP01", "productcode":"" }, { "size":"1 x 50 mL", "name":"Wash Buffer (20X)", "number":"AB237642-CMP13", "productcode":"" }, { "size":"1 x 12 mL", "name":"HRP-conjugate Probe", "number":"AB237642-CMP02", "productcode":"" }, { "size":"1 x 12 mL", "name":"Stop Solution", "number":"AB237642-CMP12", "productcode":"" }, { "size":"1 x 12 mL", "name":"TMB substrate", "number":"AB237642-CMP14", "productcode":"" }, { "size":"2 x 1 Unit", "name":"Plate sealers", "number":"AB237642-CMP11", "productcode":"" }, { "size":"1 x 1 Unit", "name":"Micro ELISA Plate", "number":"AB237642-CMP10", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S3 (10 µg/mL)", "number":"AB237642-CMP05", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S7 (Low Control)", "number":"AB237642-CMP09", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S6 (High Control)", "number":"AB237642-CMP08", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S5 (0 µg/mL)", "number":"AB237642-CMP07", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S4 (3 µg/mL)", "number":"AB237642-CMP06", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S1 (100 µg/mL)", "number":"AB237642-CMP03", "productcode":"" }, { "size":"1 x 300 µL", "name":"Bevacizumab Standard S2 (30 µg/mL)", "number":"AB237642-CMP04", "productcode":"" } ] } } }

특성 및 보관 정보

배송 시 보관 조건
Blue Ice
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
+4°C
보관 정보
+4°C

제품 프로토콜

제품이 사용된 논문 (3)

Recent publications for all applications. Explore the 전체 목록 and refine your search

PloS one 19:e0316035 PubMed39700124

2024

Plasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration.

Applications

Unspecified application

Species

Unspecified reactive species

Masashi Okawa,Munekazu Yamakuchi,Aryal Bibek,Kazunori Takenouchi,Drew N Maywar,Shingo Yamada,Keiichi Inoue,Kazuhiko Higurashi,Junichi Nakazawa,Masahiro Kawahira,Tomoko Kodama,Kiyonori Tanoue,Yoko Oyama,Sadayuki Higashi,Chieko Fujisaki,Hirohito Hashinokuchi,Akito Tabaru,Hideaki Kanda,Shuji Tachioka,Yutaka Imoto,Teruto Hashiguchi,Yoshiharu Soga

Neuro-oncology practice 10:592-595 PubMed38009115

2023

Plasma exchange as a tool for removal of bevacizumab: Highlighting application for urgent surgery.

Applications

Unspecified application

Species

Unspecified reactive species

Bryan J Neth,Jeffrey L Winters,Revathi Thirumushi Sairaj,Ali Gharibi Loron,Masum Rahman,Renee Hirte,Cecile Riviere-Cazaux,Michael W Ruff,Terry C Burns

Frontiers in oncology 12:947013 PubMed36110939

2022

Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab.

Applications

Unspecified application

Species

Unspecified reactive species

Toshimitsu Tanaka,Hiroyuki Suzuki,Tomoyuki Ushijima,Sachiko Nagasu,Yoshito Akagi,Takumi Kawaguchi,Keisuke Miwa
제품이 사용된 논문 모두 보기
websiteProtocolBooklet
en

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com